封面
市场调查报告书
商品编码
1812479

脉衝电场消融(PFA) 市场按组件、模式、适应症、最终用户和地区划分

Pulsed Field Ablation Market, By Component, By Modality By Indication, By End User Hospitals, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

脉衝电场消融(PFA) 市场规模预计在 2025 年达到 16.7 亿美元,预计到 2032 年将达到 119.7 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 32.5%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 16.7亿美元
效能数据 2020年至2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 32.50% 2032年的价值预测 119.7亿美元

脉衝电场消融(PFA) 的全球市场代表了心臟电生理学的革命性进步,它提供了一种非热消融技术,改变了心房颤动和其他心律不整的治疗模式。

脉衝电场消融(PFA) 使用微秒高压电脉衝对目标心臟组织进行不可逆电穿孔,从而实现精准消融,同时保护周围结构。这种创新方法解决了传统热消融方法(包括射频和冷冻消融)的重大局限性,显着降低了对邻近器官(例如食道、呼吸神经和肺静脉)造成附带损伤的风险。

该技术的组织选择性特性使循环系统能够获得更安全、更有效率的消融效果,从而减少手术併发症并改善患者预后。随着全球医疗保健系统优先考虑微创心臟介入和精准医疗方法,脉衝场消融 (PFA) 技术在电生理学家和心臟中心的认可度日益提升。该市场涵盖各种专为脉衝电场消融(PFA) 手术设计的导管系统、发生器和辅助设备,持续创新正在推动已开发市场和新兴市场的产品开发和临床应用。

市场动态

全球脉衝电场消融(PFA) 市场的主要驱动力在于心房颤动在全球的盛行率不断上升,影响数百万患者,并对有效安全的消融技术产生了巨大的需求。人口老化,加上心血管疾病、高血压和糖尿病的盛行率不断上升,显着导致了需要心导管电气烧灼术治疗的患者群体不断扩大。 PFA 相对于传统热消融方法的技术优势是市场的关键驱动力,因为它可以缩短手术时间、降低併发症发生率并改善临床疗效,从而鼓励电生理学家广泛采用。

优惠的报销政策以及来自FDA和CE认证等主要机构的监管核准正在加速市场渗透,同时医疗设备製造商加大研发投入也持续推动着技术创新和产品升级。然而,市场成长面临一些限制因素,包括PFA系统所需的高额初始资本投入、精通PFA技术的电生理学家数量有限,以及与成熟的热消融技术相比,人们对其长期疗效数据的担忧。此外,新设备核准的严格监管要求以及PFA技术潜在的技术复杂性可能会阻碍某些地区的市场扩张。然而,在医疗基础设施改善、医疗旅游业蓬勃发展以及人们对先进心臟护理日益增长的推动下,新兴市场仍蕴藏着巨大的商机。

本次调查的主要特点

  • 本报告对全球脉衝电场消融(PFA) 市场进行了详细分析,并提供了预测期 (2025-2032) 的市场规模(十亿美元)和年复合成长率(CAGR%),以 2024 年为基准年。
  • 它还强调了各个领域的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、性能和策略等参数概述了全球脉衝电场消融(PFA) 市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、最新策略、市场扩张和行销策略做出明智的决策。
  • 全球脉衝场消融市场报告涉及该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过用于分析全球脉衝场消融市场的各种策略矩阵更轻鬆地做出决策。

目录

第 1 章:调查目标与先决条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章:市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业趋势

4. 2020-2032 年全球脉衝电场消融(PFA) 市场(按组件划分)

  • 导管
  • 发电机
  • 电极
  • 其他的

5. 2020 年至 2032 年全球脉衝电场消融(PFA) 市场(依方式)

  • 独立系统
  • 整合系统

6. 2020 年至 2032 年全球脉衝电场消融(PFA) 市场

  • 心房颤动
  • 除了心臟

7. 2020-2032 年全球脉衝电场消融(PFA) 市场(按最终用户)

  • 医院
  • 专科诊所
  • 心导管实验室
  • 门诊手术中心
  • 研究和学术机构

8. 2020-2032 年全球脉衝电场消融(PFA) 市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第九章 竞争态势

  • Medtronic
  • Boston Scientific
  • Abbott Laboratories
  • Johnson & Johnson
  • Philips Healthcare
  • AtriCure
  • CardioFocus
  • Biotronik
  • Stereotaxis
  • ConMed Corporation
  • Endosmart
  • MicroPort Scientific Corporation
  • Sorin Group(now part of LivaNova)
  • CryoLife
  • Hansen Medical

第 10 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第 11 章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8477

Pulsed Field Ablation Market is estimated to be valued at USD 1.67 Bn in 2025 and is expected to reach USD 11.97 Bn by 2032, growing at a compound annual growth rate (CAGR) of 32.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.67 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 32.50% 2032 Value Projection: USD 11.97 Bn

The global pulsed field ablation market represents a revolutionary advancement in cardiac electrophysiology, offering a non-thermal ablation technology that has transformed the treatment landscape for atrial fibrillation and other cardiac arrhythmias.

Pulsed Field Ablation (PFA) utilizes high-voltage electrical pulses delivered in microsecond durations to create irreversible electroporation in targeted cardiac tissue, resulting in precise ablation while preserving surrounding structures. This innovative approach addresses critical limitations of traditional thermal ablation methods, including radiofrequency and cryoablation, by significantly reducing the risk of collateral damage to adjacent organs such as the esophagus, phrenic nerve, and pulmonary veins.

The technology's tissue-selective properties enable cardiologists to achieve effective ablation outcomes with enhanced safety profiles, leading to reduced procedural complications and improved patient outcomes. As healthcare systems worldwide prioritize minimally invasive cardiac interventions and precision medicine approaches, PFA technology has gained substantial traction among electrophysiologists and cardiac centers. The market encompasses various catheter systems, generators, and ancillary equipment designed specifically for pulsed field ablation procedures, with continuous technological innovations driving product development and clinical adoption across developed and emerging the healthcare markets globally.

Market Dynamics

The global pulsed field ablation market is primarily driven by the increasing prevalence of atrial fibrillation worldwide, affecting millions of patients and creating substantial demand for effective and safer ablation technologies. The growing aging population, coupled with rising incidence of cardiovascular diseases, hypertension, and diabetes, significantly contributes to the expanding patient pool requiring cardiac ablation procedures. Technological superiority of PFA over conventional thermal ablation methods serves as a major market driver, offering reduced procedure times, lower complication rates, and improved clinical outcomes, thereby encouraging widespread adoption among electrophysiologists.

Favorable reimbursement policies and regulatory approvals from key authorities including FDA and CE marking have accelerated market penetration, while increasing investments in research and development by medical device manufacturers continue to drive innovation and product enhancement. However, market growth faces certain restraints including high initial capital investments required for PFA systems, limited availability of trained electrophysiologists proficient in PFA procedures, and concerns regarding long-term efficacy data compared to established thermal ablation techniques. Additionally, stringent regulatory requirements for new device approvals and potential technical complexities associated with PFA procedures may impede market expansion in certain regions. Nevertheless, significant opportunities exist in emerging markets with improving healthcare infrastructure, growing medical tourism, and increasing awareness about advanced cardiac treatments.

Key Features of the Study

  • This report provides in-depth analysis of the global pulsed field ablation market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global pulsed field ablation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott Laboratories, Johnson & Johnson, Philips Healthcare, AtriCure, CardioFocus, Biotronik, Stereotaxis, ConMed Corporation, Endosmart, MicroPort Scientific Corporation, Sorin Group (now part of LivaNova), CryoLife, and Hansen Medical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global pulsed field ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pulsed field ablation market.

Market Segmentation

  • Component Insights (Revenue, USD Bn, 2020 - 2032)
    • Catheters
    • Generators
    • Electrodes
    • Other Accessories
  • Modality Insights (Revenue, USD Bn, 2020 - 2032)
    • Standalone Systems
    • Integrated Systems
  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Atrial Fibrillation
    • Non-Cardiac Applications
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Specialty Clinics
    • Cardiac Catheterization Labs
    • Ambulatory Surgical Centers
    • Research and Academic Institutes
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Medtronic
    • Boston Scientific
    • Abbott Laboratories
    • Johnson & Johnson
    • Philips Healthcare
    • AtriCure
    • CardioFocus
    • Biotronik
    • Stereotaxis
    • ConMed Corporation
    • Endosmart
    • MicroPort Scientific Corporation
    • Sorin Group (now part of LivaNova)
    • CryoLife
    • Hansen Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Pulsed Field Ablation Market, By Component
    • Global Pulsed Field Ablation Market, By Modality
    • Global Pulsed Field Ablation Market, By Indication
    • Global Pulsed Field Ablation Market, By End User
    • Global Pulsed Field Ablation Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Pulsed Field Ablation Market, By Component, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Generators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Electrodes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Pulsed Field Ablation Market, By Modality, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Standalone Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Integrated Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Pulsed Field Ablation Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Atrial Fibrillation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Non-Cardiac Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Pulsed Field Ablation Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiac Catheterization Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Pulsed Field Ablation Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Component, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Component, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Component, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Component, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Component, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Component, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AtriCure
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CardioFocus
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biotronik
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stereotaxis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ConMed Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Endosmart
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MicroPort Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sorin Group (now part of LivaNova)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CryoLife
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hansen Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us